Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890823840> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2890823840 endingPage "8049" @default.
- W2890823840 startingPage "8049" @default.
- W2890823840 abstract "8049 Background: Monoclonal gammopathy of unknown significance (MGUS) and smoldering multiple myeloma (SMM) are monoclonal gammopathies that precede multiple myeloma (MM). Although considered asymptomatic, patients diagnosed with these conditions are at greatly increased risk of developing MM. There is currently limited to no information on quality of life (QOL) or cancer worry/anxiety burden for patients with MGUS and SMM. Methods: We implemented a longitudinal QOL and cancer-related worry assessment in an observational cohort study of MGUS and SMM patients at MD Anderson Cancer Center (expected total enrollment of N = 200). Questionnaires included the QLQ-C30 cancer QOL tool and the MY20 myeloma-specific module, as well as questions to measure cancer worry. In this preliminary data analysis, a total of 46 patients completed the baseline questionnaires (MGUS = 17; SMM = 29). Results: Overall, individuals with MGUS have a worse QOL compared to SMM patients with MGUS patients reporting a > 12 point lower Global QOL score (71.6 vs 83.9; P = 0.035). Significant differences were also observed for Physical Functioning (P = 0.012), Nausea/Vomiting (P = 0.045), and Pain (P = 0.027). For myeloma-specific QOL and symptoms, MGUS patients again reported higher levels of Back Pain (P = 0.017), Burning/Sore Eyes (P = 0.021), Restlessness/Agitation (P = 0.026), and Tingling in Hands/Feet (P = 0.031) compared to SMM patients. This increase in reported QOL burden corresponded to MGUS patients less feeling in control of their MM risk compared to SMM patients (P = 0.0038). Conclusions: Patients with MGUS self-reported a high QOL burden that was often greater than SMM patients and more closely in line with MM-specific or overall cancer reference values. Further, a sense of loss of control of their MM risk is heightened in MGUS patients. Together, even though MGUS is considered clinically asymptomatic, patients diagnosed with this condition are experiencing reduced QOL is impacting their overall well-being. These results suggest potential opportunities for interventional strategies to improve the lives of patients with monoclonal gammopathies. This work was supported in part by MD Anderson’s Cancer Center Support Grant P30 CA016672." @default.
- W2890823840 created "2018-09-27" @default.
- W2890823840 creator A5003048403 @default.
- W2890823840 creator A5006999367 @default.
- W2890823840 creator A5008785159 @default.
- W2890823840 creator A5012687041 @default.
- W2890823840 creator A5017057018 @default.
- W2890823840 creator A5022335997 @default.
- W2890823840 creator A5038235561 @default.
- W2890823840 creator A5049573305 @default.
- W2890823840 creator A5055929208 @default.
- W2890823840 creator A5060313982 @default.
- W2890823840 creator A5091539378 @default.
- W2890823840 date "2018-05-20" @default.
- W2890823840 modified "2023-10-01" @default.
- W2890823840 title "Quality of life and cancer worry in a follow-up cohort of patients with asymptomatic monoclonal gammopathies." @default.
- W2890823840 doi "https://doi.org/10.1200/jco.2018.36.15_suppl.8049" @default.
- W2890823840 hasPublicationYear "2018" @default.
- W2890823840 type Work @default.
- W2890823840 sameAs 2890823840 @default.
- W2890823840 citedByCount "8" @default.
- W2890823840 countsByYear W28908238402019 @default.
- W2890823840 countsByYear W28908238402020 @default.
- W2890823840 countsByYear W28908238402022 @default.
- W2890823840 countsByYear W28908238402023 @default.
- W2890823840 crossrefType "journal-article" @default.
- W2890823840 hasAuthorship W2890823840A5003048403 @default.
- W2890823840 hasAuthorship W2890823840A5006999367 @default.
- W2890823840 hasAuthorship W2890823840A5008785159 @default.
- W2890823840 hasAuthorship W2890823840A5012687041 @default.
- W2890823840 hasAuthorship W2890823840A5017057018 @default.
- W2890823840 hasAuthorship W2890823840A5022335997 @default.
- W2890823840 hasAuthorship W2890823840A5038235561 @default.
- W2890823840 hasAuthorship W2890823840A5049573305 @default.
- W2890823840 hasAuthorship W2890823840A5055929208 @default.
- W2890823840 hasAuthorship W2890823840A5060313982 @default.
- W2890823840 hasAuthorship W2890823840A5091539378 @default.
- W2890823840 hasConcept C118552586 @default.
- W2890823840 hasConcept C121608353 @default.
- W2890823840 hasConcept C126322002 @default.
- W2890823840 hasConcept C143998085 @default.
- W2890823840 hasConcept C159110408 @default.
- W2890823840 hasConcept C159654299 @default.
- W2890823840 hasConcept C163864487 @default.
- W2890823840 hasConcept C1862650 @default.
- W2890823840 hasConcept C203014093 @default.
- W2890823840 hasConcept C2776364478 @default.
- W2890823840 hasConcept C2777250017 @default.
- W2890823840 hasConcept C2777910003 @default.
- W2890823840 hasConcept C2779951463 @default.
- W2890823840 hasConcept C2779978724 @default.
- W2890823840 hasConcept C2780580376 @default.
- W2890823840 hasConcept C542903549 @default.
- W2890823840 hasConcept C558461103 @default.
- W2890823840 hasConcept C71924100 @default.
- W2890823840 hasConcept C72563966 @default.
- W2890823840 hasConceptScore W2890823840C118552586 @default.
- W2890823840 hasConceptScore W2890823840C121608353 @default.
- W2890823840 hasConceptScore W2890823840C126322002 @default.
- W2890823840 hasConceptScore W2890823840C143998085 @default.
- W2890823840 hasConceptScore W2890823840C159110408 @default.
- W2890823840 hasConceptScore W2890823840C159654299 @default.
- W2890823840 hasConceptScore W2890823840C163864487 @default.
- W2890823840 hasConceptScore W2890823840C1862650 @default.
- W2890823840 hasConceptScore W2890823840C203014093 @default.
- W2890823840 hasConceptScore W2890823840C2776364478 @default.
- W2890823840 hasConceptScore W2890823840C2777250017 @default.
- W2890823840 hasConceptScore W2890823840C2777910003 @default.
- W2890823840 hasConceptScore W2890823840C2779951463 @default.
- W2890823840 hasConceptScore W2890823840C2779978724 @default.
- W2890823840 hasConceptScore W2890823840C2780580376 @default.
- W2890823840 hasConceptScore W2890823840C542903549 @default.
- W2890823840 hasConceptScore W2890823840C558461103 @default.
- W2890823840 hasConceptScore W2890823840C71924100 @default.
- W2890823840 hasConceptScore W2890823840C72563966 @default.
- W2890823840 hasIssue "15_suppl" @default.
- W2890823840 hasLocation W28908238401 @default.
- W2890823840 hasOpenAccess W2890823840 @default.
- W2890823840 hasPrimaryLocation W28908238401 @default.
- W2890823840 hasRelatedWork W1995188757 @default.
- W2890823840 hasRelatedWork W2000452917 @default.
- W2890823840 hasRelatedWork W2016679923 @default.
- W2890823840 hasRelatedWork W2018154290 @default.
- W2890823840 hasRelatedWork W2116001782 @default.
- W2890823840 hasRelatedWork W2551784955 @default.
- W2890823840 hasRelatedWork W2727005442 @default.
- W2890823840 hasRelatedWork W3129396458 @default.
- W2890823840 hasRelatedWork W4229900919 @default.
- W2890823840 hasRelatedWork W4281392583 @default.
- W2890823840 hasVolume "36" @default.
- W2890823840 isParatext "false" @default.
- W2890823840 isRetracted "false" @default.
- W2890823840 magId "2890823840" @default.
- W2890823840 workType "article" @default.